Symbols

TAK

Takeda Pharmaceutical·NYSE

--(--)

8.22 / 10

Outperform

The fund flow profile scores 8.22/10, demonstrating exceptionally strong fund flow dynamics. Favorable overall, block, Medium, and Extra-large movements are tempered by challenging Small and Large dynamics, supporting highly favorable flow assessment.

Fund Flow Rating

Is money flowing into or out of TAK?

TAK holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.22/10 (Outperform).